No Data
No Data
AIM ImmunoTech Aligns Compensation With Shareholder Strategy
AIM ImmunoTech Refutes Activist Group's False And Misleading Claims; Urges Shareholders To Safeguard Aim By Voting "For" All Of The Board's Incumbent Candidates And Discarding Any Proxy Materials Received From The Activist Group
Express News | AIM ImmunoTech : Independent Board Members to Receive 100% of Director Compensation in Aim Stock
AIM ImmunoTech Announces Cash Conservation Plan
Kellner Group Isses Letter to Stockholders of AIM ImmunoTech
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
No Data
No Data